Ask AI

Advancing Adjunctive Strategies: Optimizing Care for Residual Symptoms in Major Depressive Disorder

This program examines adjunctive treatment for major depressive disorder, emphasizing residual symptoms such as anhedonia and cognitive impairment. A multimodal curriculum combines expert-led live and on-demand education with interactive case-based learning and practical clinical resources. Real-world outcomes analysis will assess improvements in treatment sequencing, individualized augmentation, dosing, monitoring, and functional recovery.

Share

Program Content

Events

Activities

MDD Adjunct
From Partial Response to Remission: Choosing the Next Step in Major Depressive Disorder
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 19, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc.